MUSCARINIC ACETYLCHOLINE RECEPTOR M1

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 16:56:39 GMT 2025` Edited by `admin` on `Tue Apr 01 16:56:39 GMT 2025`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	V23K99CV7G
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CHRM1

Preferred Name

English

MUSCARINIC ACETYLCHOLINE RECEPTOR M1

Common Name

English

acetylcholine receptor, muscarinic 1

Common Name

English

M1

Common Name

English

Code System Code Type Description

PHAROS

P11229

Created by admin on Tue Apr 01 16:56:39 GMT 2025 , Edited by admin on Tue Apr 01 16:56:39 GMT 2025

PRIMARY

FDA UNII

V23K99CV7G

Created by admin on Tue Apr 01 16:56:39 GMT 2025 , Edited by admin on Tue Apr 01 16:56:39 GMT 2025

PRIMARY

UNIPROT

P11229

Created by admin on Tue Apr 01 16:56:39 GMT 2025 , Edited by admin on Tue Apr 01 16:56:39 GMT 2025

PRIMARY

From	To
1_98	1_178

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_2
N	1_12

Related Record Type Details


					EF9QE9L2JL

HTL-9936

AGONIST -> TARGET

Comments:

full agonist; pERK1/2

Qualification:

EC50

Amount:


					XJR8Y07LJO

IMIDAFENACIN

INHIBITOR -> TARGET

Amount:


					V92SO9WP2I

GLYCOPYRROLATE

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					QDP6S14W5W

TAZOMELINE

AGONIST -> TARGET

Amount:


					JAJ5K83HJC

LLNL-02

ACTIVATOR -> TARGET

Comments:

Promising, novel CNS-permeable oxime ACHE reactivator.

Amount:


					98IW5HAV1N

VEDACLIDINE

INHIBITOR -> TARGET

Amount:


					WHE7A56U7K

TOLTERODINE

INHIBITOR -> TARGET


					3G0285N20N

Pirenzepine

INHIBITOR -> TARGET

Comments:

Pirenzepine is a selective muscarinic M1 receptor antagonist

Amount:


					I76F4SHP7J

CYCLOPENTOLATE

INHIBITOR -> TARGET


					WV3E0S3IQB

VELUFENACIN

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					KG2XA994SN

[3H]Pirenzepine

RADIOLIGAND->TARGET

Qualification:

Kd

Amount:


					J2R869A8YF

SUCCINYLCHOLINE

AGONIST -> TARGET

Amount:


					D42OWK5383

ACOTIAMIDE

INHIBITOR -> TARGET

Amount:


					6RC5V8B7PO

TRIHEXYPHENIDYL

INHIBITOR -> TARGET

Amount:


					T83BJV98CM

AZD-6088

PARTIAL AGONIST->TARGET

Amount:


					9ORI6L73CJ

XANOMELINE

AGONIST -> TARGET

Amount:


					5BRQ29UUB7

Aroxybutynin

INHIBITOR -> TARGET

Amount:


					JJH94R3PWB

NERATINIB

INHIBITOR->OFF-TARGET

Comments:

Radioligand binding assay

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					K17VY42F6C

ACLIDINIUM

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					KFR8EX22KX

AF-DX-384

INHIBITOR -> TARGET

Qualification:

Kd

Amount:


					A6X64T4LZ4

THRX-195518

INHIBITOR -> TARGET

Comments:

THRX-195518 possesses activity at target muscarinic receptors that was slightly lower (approximately one-third to one-tenth) than revefenacin.

Interaction Type:

BINDING

Qualification:

Ki

Amount:


					A8910SQJ1U

SOLIFENACIN

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					59XC9G796Y

TAK-071

POSITIVE ALLOSTERIC MODULATOR->TARGET


					01MI4Q9DI3

Pilocarpine

AGONIST -> TARGET


					R9X77R42FN

MILAMELINE

AGONIST -> TARGET

Amount:


					838F01T721

PALIPERIDONE

NON-INHIBITOR->OFF TARGET

Interaction Type:

NON-INHIBITOR

Qualification:

Ki

Amount:


					1O8VSL798T

TALSACLIDINE

AGONIST -> TARGET

Amount:


					G2AE2VE07O

REVEFENACIN

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

Kd

Amount:


					8Y164V895Y

CARBACHOL

AGONIST -> TARGET


					K9P6MC7092

Oxybutynin

INHIBITOR -> TARGET


					JJH94R3PWB

NERATINIB

INHIBITOR->OFF-TARGET

Amount:


					5ASJ6HUZ7D

DOXEPIN

INHIBITOR -> TARGET

Amount:


					P8P92V596C

SABCOMELINE

PARTIAL AGONIST->TARGET

Amount:


					3W7L15V40W

REVATROPATE

INHIBITOR -> TARGET

Amount:


					L6UH7ZF8HC

RISPERIDONE

NON-INHIBITOR->OFF TARGET

Qualification:

Ki

Amount:


					V3H1ZVV9S6

Norquetiapine

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					4XFD7B36M6

ALVAMELINE

PARTIAL AGONIST->TARGET

Amount:


					9GHO88L89C

REVOSIMELINE

AGONIST -> TARGET

Amount:


					K9V0CDQ56E

CEVIMELINE

AGONIST -> TARGET

Amount:


					NVJ76B897D

METHOCTRAMINE FREE BASE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					9A5LBZ98YY

FP-TZTP F-18

RADIOLIGAND->TARGET

Qualification:

Ki

Amount:


					9T210MMZ3F

BLARCAMESINE

MODULATOR->TARGET


					7C0697DR9I

ATROPINE

INHIBITOR -> TARGET

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_230] [1_428] [1_455]				THREONINE PHOSPHATE	3L4WX7B1EI
AMINO ACID SUBSTITUTION	[1_451] [1_457]				DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL